HLA-G may also be pathologically expressed by (i) non-rejected allografts [3], [4], (ii) lesion-infiltrating antigen presenting cells (APC) during inflammatory diseases [5], [6], and (iii) tumor tissues and their tumor infiltrating APC [7]–[11]. Here, HLA-G is linked to neoplasm.